AmerisourceBergen Acquires Trent Drugs (Wholesale)

On October 4, 2005, AmerisourceBergen Corp. completed its acquisition of Trent Drugs (Wholesale) Ltd., one of the largest national pharmaceutical distributors in Canada, for US$83 million including the assumption of approximately US$43 million in debt. The acquisition was financed by a C$135 million unsecured revolving credit facility with a syndicate of lenders, led by the Bank of Nova Scotia, as administrative agent.
The AmerisourceBergen legal team was led by Steven Biener, AmerisourceBergen's assistant general counsel, and Craig Godshall and Megan Horwitz of Dechert LLP in Philadelphia. Paul Salvatore, David Migicovsky, Barbara Nicholls, Tim Thomas and Dirk Bouwer of Perley-Robertson, Hill & McDougall LLP in Ottawa represented AmerisourceBergen on corporate, employment and real estate aspects of the acquisition. Bruce Chapple, John Clifford, Omar Wakil and Lydia Wakulowsky of McMillan Binch Mendelsohn LLP in Toronto advised on competition and other regulatory matters.

Trent was represented by John Moss and Dan Coderre of Soloway Wright LLP in Kingston.

On the financing, AmerisourceBergen was represented by its deputy general counsel, John Chou and Steven Biener, and in the US by Craig Godshall and Megan Horwitz of Dechert. Jeffrey Rogers, Michael Hollinger and Simon Williams provided Canadian advice on the financing with assistance from Michael Friedman (tax), all from McMillan Binch Mendelsohn.

The administrative agent to the lending syndicate was represented in the US by Andrew Mattei, Shane Deaton and Carol Morrison of Mayer, Brown, Rowe & Maw LLP in New York, and in Canada by Stephen Furlan of McCarthy Tétrault LLP.